TL;DR
Zepbound currently produces the strongest weight-loss results of any FDA-approved medication. If price, supply, or side effects push you to look at alternatives, several options use the same or related active ingredients.
Why people look for Zepbound alternatives
Before evaluating alternatives, it helps to identify which pain is driving the search — different switching reasons point to different replacements.
List price too high
Zepbound's cash price is ~$1,059/mo. Compounded tirzepatide is $200-450/mo via telehealth.
Side effects intolerable
Tirzepatide causes more nausea and GI upset than semaglutide for some patients. Wegovy may be better tolerated.
Shortage / supply issues
Zepbound supply has been tight at retail pharmacies; compounded versions and semaglutide alternatives are workarounds.
Insurance won't cover
Many insurers require step-therapy (try Wegovy or Saxenda first) before approving Zepbound.
At-a-glance comparison
5 alternatives to Zepbound, ordered by how often they’re chosen as direct replacements.
| Alternative | Best for | Type |
|---|---|---|
| Wegovy → | Patients with tirzepatide side-effect intolerance. | FDA brand |
| Compounded tirzepatide → | Cost-sensitive patients comfortable with compounded. | Compounded |
| Mounjaro → | Diabetic patients (insurance coverage path). | FDA brand |
| Compounded semaglutide → | Maximum cost savings, semaglutide-tolerant patients. | Compounded |
| Ozempic → | Diabetic patients using insurance. | FDA brand |
Detailed breakdown of each alternative
1. Wegovy
FDA brandSemaglutide — slightly less weight loss but often better tolerated.
- Best for
- Patients with tirzepatide side-effect intolerance.
- Honest limitation
- Lower average efficacy than Zepbound.
2. Compounded tirzepatide
CompoundedSame active ingredient at 50-70% lower cost.
- Best for
- Cost-sensitive patients comfortable with compounded.
- Honest limitation
- Not FDA-approved as a finished product.
3. Mounjaro
FDA brandSame molecule (tirzepatide) — approved for diabetes.
- Best for
- Diabetic patients (insurance coverage path).
- Honest limitation
- Off-label for weight loss.
4. Compounded semaglutide
CompoundedCheapest GLP-1 option via telehealth.
- Best for
- Maximum cost savings, semaglutide-tolerant patients.
- Honest limitation
- Lower efficacy than tirzepatide; not FDA-approved.
5. Ozempic
FDA brandSemaglutide for diabetes patients with insurance coverage.
- Best for
- Diabetic patients using insurance.
- Honest limitation
- Off-label for weight loss; less efficacy than tirzepatide.
Quick pick: which alternative for which goal
Same data, narrowed to a single recommendation per common goal. Use this when you already know what matters most.
If you want
Want cheaper tirzepatide
Our pick
Compounded tirzepatide →Same molecule, telehealth pricing.
When to stay with Zepbound
Switching isn’t always the right answer. If your current setup meets your needs on cost, coverage, and outcomes, the friction of switching may not be worth it. Read our full Zepbound review to confirm whether the issues you’re hitting are addressable without changing medications.
FAQ — Zepbound alternatives
What is the best alternative to Zepbound?
For continued tirzepatide therapy at lower cost, compounded tirzepatide is the leading alternative. For better tolerability, switching to Wegovy (semaglutide) is common. Both Mounjaro and compounded options exist for specific situations.
Why switch from Zepbound?
Common reasons: cost (Zepbound's ~$1,059 list price), side-effect intolerance (more nausea than semaglutide), pharmacy shortages, or insurance denial requiring step-therapy with cheaper drugs first.
Editorial summary based on published clinical data, provider websites, and public pricing. GLP1Zoom earns affiliate commissions when readers visit partner websites; this does not influence ranking decisions on this page. Full affiliate disclosure. Medical disclaimer.